Multicenter, Randomized, Active Comparator-Controlled, Double-Blind, Double-Dummy, Parallel Group, Dose-Finding Phase 2 Study Comparing the Safety of the Oral FXIa Inhibitor Asundexian with Apixaban in Patients with Atrial Fibrillation
Jonathan P Piccini, Valeria Caso, Stuart J Connolly, Keith A A Fox, Jonas Oldgren, Schuyler Jones, Diana Gorog, Vaclav Durdil, Thomas Viethen, Christoph Neumann, Hardi Mundl, Manesh R Patel
Research output: Contribution to journal › Article › peer-review
83Downloads
(Pure)
Fingerprint
Dive into the research topics of 'Multicenter, Randomized, Active Comparator-Controlled, Double-Blind, Double-Dummy, Parallel Group, Dose-Finding Phase 2 Study Comparing the Safety of the Oral FXIa Inhibitor Asundexian with Apixaban in Patients with Atrial Fibrillation'. Together they form a unique fingerprint.